O
TMO icon

OppenheimerFunds’s Thermo Fisher Scientific TMO Stock Holding History

OppenheimerFunds’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$38.6M Buy
140,997
+40,662
+41% +$10.1M 0.05% 375
2018
Q4 		$22.5M Sell
100,335
-21,366
-18% -$5.01M 0.03% 470
2018
Q3 		$29.7M Sell
121,701
-18,860
-13% -$4.34M 0.03% 486
2018
Q2 		$29.1M Sell
140,561
-248
-0.2% -$52.6K 0.03% 481
2018
Q1 		$29.1M Buy
140,809
+2,718
+2% +$570K 0.04% 462
2017
Q4 		$26.2M Sell
138,091
-2,450
-2% -$469K 0.03% 500
2017
Q3 		$26.6M Buy
140,541
+12,376
+10% +$2.24M 0.03% 474
2017
Q2 		$22.4M Sell
128,165
-365
-0.3% -$61.3K 0.03% 531
2017
Q1 		$19.7M Sell
128,530
-27,784
-18% -$4.25M 0.02% 582
2016
Q4 		$22.1M Sell
156,314
-125,486
-45% -$18.5M 0.03% 549
2016
Q3 		$44.8M Sell
281,800
-4,882
-2% -$752K 0.06% 355
2016
Q2 		$42.4M Buy
286,682
+99,360
+53% +$14.7M 0.06% 352
2016
Q1 		$26.5M Sell
187,322
-22,618
-11% -$3.03M 0.04% 474
2015
Q4 		$29.8M Sell
209,940
-26,712
-11% -$3.56M 0.04% 454
2015
Q3 		$28.9M Sell
236,652
-26,994
-10% -$3.52M 0.04% 449
2015
Q2 		$34.2M Sell
263,646
-748,435
-74% -$97.6M 0.04% 444
2015
Q1 		$136M Buy
1,012,081
+2,943
+0.3% +$379K 0.15% 179
2014
Q4 		$126M Sell
1,009,138
-1,060,540
-51% -$129M 0.14% 181
2014
Q3 		$252M Sell
2,069,678
-323,980
-14% -$39.4M 0.28% 100
2014
Q2 		$282M Sell
2,393,658
-29,250
-1% -$3.44M 0.31% 85
2014
Q1 		$291M Buy
2,422,908
+1,014,030
+72% +$121M 0.34% 75
2013
Q4 		$157M Buy
1,408,878
+863,760
+158% +$85.9M 0.19% 147
2013
Q3 		$50.2M Sell
545,118
-12,022
-2% -$1.09M 0.07% 329
2013
Q2 		$47.2M Buy
+557,140
New +$46.4M 0.07% 322

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OppenheimerFunds's TMO Position: Q1 2019 in Review

OppenheimerFunds increased its Thermo Fisher Scientific (TMO) stake by 41% in Q1 2019, buying an estimated $10.1M and bringing the position to 140,997 shares worth $38.6M. The position accounts for 0.05% of the portfolio, ranked #375.

OppenheimerFunds first reported a position in TMO in Q2 2013 and has held it in 24 quarters since. The position peaked at $291M in Q1 2014. 1,522 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

  • OppenheimerFunds held 140,997 shares of Thermo Fisher Scientific worth $38.6M as of Q1 2019.
  • OppenheimerFunds bought 40,662 Thermo Fisher Scientific shares in Q1 2019, an estimated $10.1M.
  • Thermo Fisher Scientific made up 0.05% of OppenheimerFunds's portfolio in Q1 2019, its #375 holding.
  • OppenheimerFunds first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Thermo Fisher Scientific position peaked at $291M in Q1 2014.
  • 1,522 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.